Jump to content

Chondroitinase treatment

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Godsy (talk | contribs) at 22:28, 19 July 2016 (Undid revision 727523477 by Tom.Reding (talk) this is clearly a stub). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Chondroitinase treatment is a treatment of proteoglycans, a protein in the fluid among cells where (among other things) they affect neural activity (communication, plasticity).[1] Chondroitinase treatment has been shown to allow adults vision to be restored as far as ocular dominance is concerned.[2] Moreover, there is some evidence that Chondroitinase could be used for the treatment of spinal injuries.[3]

See also

References

Template:Research help

  1. ^ Cambridge Centre for Brain Repair, School of Clinical Medicine, Cambridge Centre for Brain Repair. Plasticity and the extracellular matrix.
  2. ^ Hensch TK (2005). "Critical period mechanisms in developing visual cortex". Curr. Top. Dev. Biol. 69: 215–37. doi:10.1016/S0070-2153(05)69008-4. PMID 16243601.
  3. ^ "Spinal injury regeneration hope". BBC NEWS, online. 17 February 2008. Retrieved 2009-12-31Template:Inconsistent citations{{cite news}}: CS1 maint: postscript (link)